Oncologic Drugs Advisory Committee to Discuss Johnson & Johnson and Legend Biotech Biologics License Application

Silver Spring, Maryland – On Friday, the FDA’s Oncologic Drugs Advisory Committee will convene to review Johnson & Johnson and Legend Biotech Corporation’s joint application for Carvykti, a treatment for patients with relapsed or refractory multiple myeloma. This particular session aims to assess the risks and benefits of Carvykti, specifically looking at the results of the CARTITUDE-4 trial to determine its efficacy in this patient population. The main focus of the discussion will be on …

Read more

Technical Difficulties: Application Error Causes Page Unavailability, Support Team Working to Resolve Issue

London, UK – Users attempting to access a certain page are currently encountering an access error. The page in question is currently unavailable, prompting users to wait and try again later. For assistance, users are directed to visit help.ft.com. Additionally, a timestamp of “Fri, 02 Feb 2024 11:04:07 GMT” and a request ID of “8def9de85ce2f1fabb2ea6a7e0695e26378fcfcdb201ccb004c2fb62ac162d37” have been provided to aid the support team in resolving the issue.